First Nebraska Trust’s Boston Scientific BSX Stock Holding History

First Nebraska Trust’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.59M	Sell	105,091 -100	-0.1%	-$8K	0.61%	38
2025 Q4	$10M	Sell	105,191 -1,551	-1%	-$152K	0.92%	27
2025 Q3	$10.4M	Sell	106,742 -273	-0.3%	-$28.3K	0.94%	26
2025 Q2	$11.5M	Sell	107,015 -1,041	-1%	-$105K	1.1%	22
2025 Q1	$10.9M	Sell	108,056 -1,133	-1%	-$114K	1.08%	24
2024 Q4	$9.75M	Buy	109,189 +840	+0.8%	+$73.9K	0.94%	27
2024 Q3	$9.08M	Sell	108,349 -1,090	-1%	-$85.9K	0.88%	29
2024 Q2	$8.43M	Sell	109,439 -692	-0.6%	-$50.7K	0.87%	31
2024 Q1	$7.54M	Sell	110,131 -1,463	-1%	-$94.1K	0.78%	35
2023 Q4	$6.45M	Sell	111,594 -2,000	-2%	-$107K	0.74%	35
2023 Q3	$6M	Sell	113,594 -948	-0.8%	-$49.7K	0.74%	33
2023 Q2	$6.2M	Sell	114,542 -349	-0.3%	-$18.2K	0.74%	33
2023 Q1	$5.75M	Sell	114,891 -140	-0.1%	-$6.6K	0.72%	33
2022 Q4	$5.32M	Sell	115,031 -1,210	-1%	-$52.4K	0.69%	39
2022 Q3	$4.5M	Buy	116,241 +6,329	+6%	+$254K	0.65%	38
2022 Q2	$4.1M	Buy	109,912 +10,950	+11%	+$446K	0.54%	42
2022 Q1	$4.38M	Buy	98,962 +4,360	+5%	+$189K	0.52%	41
2021 Q4	$4.02M	Buy	94,602 +7,800	+9%	+$328K	0.48%	42
2021 Q3	$3.77M	Buy	86,802 +1,756	+2%	+$77.7K	0.49%	45
2021 Q2	$3.64M	Buy	85,046 +6,375	+8%	+$268K	0.47%	46
2021 Q1	$3.04M	Buy	78,671 +3,680	+5%	+$139K	0.41%	49
2020 Q4	$2.7M	Buy	74,991 +4,199	+6%	+$151K	0.39%	48
2020 Q3	$2.7M	Buy	70,792 +1,165	+2%	+$44.9K	0.46%	46
2020 Q2	$2.44M	Buy	69,627 +10,801	+18%	+$389K	0.45%	49
2020 Q1	$1.92M	Sell	58,826 -720	-1%	-$28.1K	0.42%	50
2019 Q4	$2.69M	Sell	59,546 -447	-0.7%	-$18.7K	0.44%	48
2019 Q3	$2.44M	Sell	59,993 -255	-0.4%	-$10.8K	0.41%	47
2019 Q2	$2.59M	Sell	60,248 -1,569	-3%	-$60.3K	0.45%	46
2019 Q1	$2.37M	Sell	61,817 -103	-0.2%	-$3.93K	0.43%	48
2018 Q4	$2.19M	Sell	61,920 -823	-1%	-$29.8K	0.44%	45
2018 Q3	$2.42M	Sell	62,743 -637	-1%	-$22.2K	0.41%	52
2018 Q2	$2.07M	Sell	63,380 -505	-0.8%	-$15.2K	0.44%	54
2018 Q1	$1.75M	Buy	63,885 +31,500	+97%	+$856K	0.35%	57
2017 Q4	$803K	Sell	32,385 -445	-1%	-$12.3K	0.16%	71
2017 Q3	$958K	Sell	32,830 -78	-0.2%	-$2.15K	0.21%	63
2017 Q2	$912K	Sell	32,908 -390	-1%	-$10.4K	0.2%	63
2017 Q1	$828K	Buy	33,298 +60	+0.2%	+$1.46K	0.19%	63
2016 Q4	$719K	Sell	33,238 -182	-0.5%	-$3.97K	0.17%	62
2016 Q3	$795K	Sell	33,420 -135	-0.4%	-$3.22K	0.21%	61
2016 Q2	$784K	Sell	33,555 -20	-0.1%	-$433	0.2%	58
2016 Q1	$632K	Sell	33,575 -205	-0.6%	-$3.6K	0.17%	63
2015 Q4	$623K	Sell	33,780 -85	-0.3%	-$1.52K	0.19%	59
2015 Q3	$556K	Sell	33,865 -34,090	-50%	-$583K	0.18%	59
2015 Q2	$1.2M	Sell	67,955 -1,800	-3%	-$32.2K	0.37%	50
2015 Q1	$1.24M	Sell	69,755 -34,560	-33%	-$546K	0.37%	51
2014 Q4	$1.38M	Sell	104,315 -14,768	-12%	-$189K	0.4%	51
2014 Q3	$1.41M	Sell	119,083 -2,700	-2%	-$34K	0.4%	52
2014 Q2	$1.56M	Hold	121,783	–	–	0.45%	52
2014 Q1	$1.65M	Sell	121,783 -700	-0.6%	-$9.19K	0.51%	47
2013 Q4	$1.47M	Sell	122,483 -7,625	-6%	-$90.1K	0.46%	48
2013 Q3	$1.53M	Buy	+130,108	New	+$1.41M	0.53%	46

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

First Nebraska Trust's BSX Position: Q1 2026 in Review

First Nebraska Trust reduced its Boston Scientific (BSX) stake by 0.1% in Q1 2026, selling an estimated $8K and leaving 105,091 shares worth $6.59M. The position accounts for 0.61% of the portfolio, ranked #38.

First Nebraska Trust first reported a position in BSX in Q3 2013 and has held it in 51 quarters since. The position peaked at $11.5M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

First Nebraska Trust held 105,091 shares of Boston Scientific worth $6.59M as of Q1 2026.
First Nebraska Trust sold 100 Boston Scientific shares in Q1 2026, an estimated $8K.
Boston Scientific made up 0.61% of First Nebraska Trust's portfolio in Q1 2026, its #38 holding.
First Nebraska Trust first reported a position in Boston Scientific in Q3 2013 and has held it in 51 quarters since.
First Nebraska Trust's Boston Scientific position peaked at $11.5M in Q2 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on First Nebraska Trust's 13F filing for Q1 2026, filed 1 Jun 2026.